Breast cancer treatment agents

TW202629164APending Publication Date: 2026-07-16EISAI R&D MANAGEMENT CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
EISAI R&D MANAGEMENT CO LTD
Filing Date
2021-07-29
Publication Date
2026-07-16

Smart Images

  • Figure TWG2TA001069421_001
    Figure TWG2TA001069421_001
  • Figure TWG2TA001069421_002
    Figure TWG2TA001069421_002
  • Figure TWG2TA001069421_003
    Figure TWG2TA001069421_003
Patent Text Reader

Abstract

This invention discloses a breast cancer treatment agent containing 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-methamide or a pharmacologically acceptable salt thereof, and administered in combination with an estrogen receptor antagonist or an aromatase inhibitor.
Need to check novelty before this filing date? Find Prior Art